MICAL1 Inhibitors

MICAL1 inhibitors, as described here, target various signaling molecules and pathways that indirectly influence the activity of MICAL1. These inhibitors focus on modulating the actin cytoskeleton and associated signaling pathways, which are key aspects of MICAL1's function. MICAL1 is involved in redox-dependent actin filament disassembly, a critical process in cell motility, morphology, and various cellular functions. The inhibitors listed, such as NSC23766, EHop-016, and ML141, target GTPases like Rac1 and Cdc42, which are integral in actin cytoskeleton dynamics and have interactions with MICAL1. By modulating these GTPases, these inhibitors can indirectly affect MICAL1-mediated actin remodeling. Compounds like CK-666 and SMIFH2 target the Arp2/3 complex and formins, respectively, both of which are involved in actin filament formation and regulation, processes where MICAL1 plays a crucial role.

Actin-targeting agents such as Latrunculin A, Cytochalasin D, and Jasplakinolide directly affect actin polymerization or stabilization, thereby impacting the actin disassembly function of MICAL1. Blebbistatin, Y-27632, and ML7, which inhibit myosin II, ROCK, and myosin light chain kinase, respectively, are important in understanding the role of actomyosin dynamics in relation to MICAL1's function in cells. Wiskostatin's inhibition of N-WASP, a key regulator of actin polymerization, further highlights the complex network of proteins involved in actin dynamics and their indirect connection to MICAL1 activity.